Pediatr Res. 2021 Nov;90(5):966-970. doi: 10.1038/s41390-021-01402-z. Epub 2021 Feb 24.

SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.

Pediatric research

Dan M Cooper, Behnoush Afghani, Carrie L Byington, Coleen K Cunningham, Sidney Golub, Kim D Lu, Shlomit Radom-Aizik, Lainie Friedman Ross, Jasjit Singh, William E Smoyer, Candice Taylor Lucas, Jessica Tunney, Frank Zaldivar, Erlinda R Ulloa

PMID: 33627824 PMCID: PMC7903864 DOI: 10.1038/s41390-021-01402-z

Abstract

As the nation implements SARS-CoV-2 vaccination in adults at an unprecedented scale, it is now essential to focus on the prospect of SARS-CoV-2 vaccinations in pediatric populations. To date, no children younger than 12 years have been enrolled in clinical trials. Key challenges and knowledge gaps that must be addressed include (1) rationale for vaccines in children, (2) possible effects of immune maturation during childhood, (3) ethical concerns, (4) unique needs of children with developmental disorders and chronic conditions, (5) health inequities, and (6) vaccine hesitancy. Because COVID-19 is minimally symptomatic in the vast majority of children, a higher acceptable risk threshold is required when evaluating pediatric clinical trials. Profound differences in innate and adaptive immunity during childhood and adolescence are known to affect vaccine responsiveness for a variety of childhood diseases. COVID-19 and the accompanying social disruption, such as the school shutdowns, has been disproportionately damaging to minority and low-income children. In this commentary, we briefly address each of these key issues, specify research gaps, and suggest a broader learning health system approach to accelerate testing and clinical trial development for an ethical and effective strategy to implement a pediatric SARS-CoV-2 vaccine as rapidly and safely as possible. IMPACT: As the US begins an unprecedented implementation of SARS-CoV-2 vaccination, substantial knowledge gaps have yet to be addressed regarding vaccinations in the pediatric population. Maturational changes in the immune system during childhood have influenced the effectiveness of pediatric vaccines for other diseases and conditions, and could affect SARS-CoV-2 vaccine responsiveness in children. Given that COVID-19 disease is far milder in the majority of children than in adults, the risk-benefit of a pediatric SARS-CoV-2 vaccine must be carefully weighed. The needs of children with developmental disabilities and with chronic disease must be addressed. Minority and low-income children have been disproportionately adversely affected by the COVID-19 pandemic; care must be taken to address issues of health equity regarding pediatric SARS-CoV-2 vaccine trials and allocation. Research and strategies to address general vaccine hesitancy in communities must be addressed in the context of pediatric SARS-CoV-2 vaccines.

© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

References

1. AAP: Include children in COVID-19 vaccine trials (American Academy of Pediatrics, 2020); https://www.aappublications.org/news/2020/11/17/covidvaccinetrials111720 . - PubMed
2. Leeb, R. T. et al. MMWR, COVID-19 trends among school-aged children—United States, 1 March–19 September 2020.  https://www.cdc.gov/mmwr/volumes/69/wr/mm6939e2.htm . - PubMed
3. Opel, D. J., Diekema, D. S. & Ross L. F. Should we mandate a COVID-19 vaccine for children? JAMA Pediatr. 175, 125–126 (2021). - PubMed
4. American Academy of Pediatrics. Children and COVID-19: State-level data report (accessed 15 Jan 2021); https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/ . - PubMed
5. Song, X. et al. Comparison of clinical features of COVID-19 vs seasonal influenza A and B in US children. JAMA Netw. Open 3, e2020495 (2020). - PubMed
6. Flannery, B. et al. Influenza vaccine effectiveness against pediatric deaths: 2010-2014. Pediatrics 139, 2010–2014 (2017). - PubMed
7. Levin, Z., Choyke, K., Georgiou, A., Sen, S. & Karaca-Mandic, P. Trends in pediatric hospitalizations for coronavirus disease 2019. JAMA Pediatr. https://doi.org/10.1001/jamapediatrics.2020.5535 (2021). - PubMed
8. Munro, A. P. S. & Faust, S. N. Children are not COVID-19 super spreaders: time to go back to school. Arch. Dis. Child. 105, 618–619 (2020). - PubMed
9. Laxminarayan, R. et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 370, 691–697 (2020). - PubMed
10. Blaisdell, L. L., Cohn, W., Pavell, J. R., Rubin, D. S. & Vergales, J. E. Preventing and mitigating SARS-CoV-2 transmission—four overnight camps, Maine, June–August 2020. MMWR Morb. Mortal. Wkly Rep. 69, 1216–20 (2020). - PubMed
11. Dorn, E., Hancock, B., Sarakatsannis, J. & Viruleg, E. COVID-19 and Student Learning in the United States: The Hurt Could Last a Lifetime. McKinsey & Company (2020). - PubMed
12. Bramer, C. A. et al. Decline in child vaccination coverage during the COVID-19 pandemic—Michigan Care Improvement Registry, May 2016–May 2020. Am. J. Transplant. 20, 1930–1931 (2020). - PubMed
13. The Impact of Coronavirus on Food Insecurity. Feeding America (2020); https://www.feedingamerica.org/research/coronavirus-hunger-research . - PubMed
14. Dunton, G. F., Do, B. & Wang, S. D. Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the U.S. BMC Public Health. 20, 1351 (2020). - PubMed
15. Loades, M. E. et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J. Am. Acad. Child Adolesc. Psychiatry 59, 1218–1239.e3 (2020). - PubMed
16. Dooley, D. G., Bandealy, A. & Tschudy, M. M. Low-income children and coronavirus disease 2019 (COVID-19) in the US. JAMA Pediatr. 174, 924–925 (2020). - PubMed
17. World Health Organization. Draft landscape of COVID-19 candidate vaccines (accessed 19 Feb 2021); https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines . - PubMed
18. Richards, S.E. Moderna edges Pfizer in COVID-19 vaccine effectiveness—and refrigeration. National Geographic (accessed 20 Nov 2020);  https://www.nationalgeographic.com/science/2020/11/moderna-edges-pfizer-coronavirus-efficacy-and-refrigeration/ . - PubMed
19. Rossey, I., Saelens, X. Vaccines against human respiratory syncytial virus in clinical trials, where are we now? Expert Rev. Vaccines 18, 1053–1067 (2019). - PubMed
20. Mokomane, M., Kasvosve, I., de Melo, E., Pernica, J. M. & Goldfarb, D. M. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther. Adv. Infect. Dis. 5, 29–43 (2018). - PubMed
21. Schrager, L. K., Vekemens, J., Drager, N., Lewinsohn, D. M. & Olesen, O. F. The status of tuberculosis vaccine development. Lancet Infect. Dis. 20, e28–37 (2020). - PubMed
22. Basha, S., Surendran, N. & Pichichero, M. Immune responses in neonates Expert Rev. Clin. Immunol. 10, 1171–1184 (2014). - PubMed
23. Kollmann, T. R., Kampmann B., Mazmanian S. K., Marchant A. & Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity 46, 350–363 (2017). - PubMed
24. Aronoff, S. C., Hall, A. & Del Vecchio, M. T. The natural history of severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children: a systematic review. J. Pediatr. Infect. Dis. Soc. 9, 746–751 (2020). - PubMed
25. Hemati, Z. et al. Association of sleep duration with metabolic syndrome and its components in children and adolescents; a propensity score-matched analysis: the CASPIAN-V study. Diabetol. Metab. Syndr. 10, 78 (2018). - PubMed
26. Weber, D. J., Rutala, W. A., Samsa, G. P., Santimaw, J. E. & Lemon S. M. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 254, 3187–3189 (1985). - PubMed
27. Eliakim A., Swindt C., Zaldivar F., Casali P. & Cooper D. M. Reduced tetanus antibody titers in overweight children. Autoimmunity 39, 137–141 (2006). - PubMed
28. Green, W. D. & Beck, M. A. Obesity impairs the adaptive immune response to influenza virus. Ann. Am. Thorac. Soc. 14, S406–S409 (2017). - PubMed
29. Hernández-Garduño, E. Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obes. Res. Clin. Pract. 14, 375–379 (2020). - PubMed
30. States National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Research involving Children (1977). - PubMed
31. Pfizer Gets FDA Approval to Enroll Kids as Young As 12 in COVID-19 Vaccine Trial: Shots. Health News: NPR (2020); https://www.npr.org/sections/health-shots/2020/10/13/923248377/will-kids-get-a-covid-19-vaccine-pfizer-to-expand-trial-to-ages-12-and-up . - PubMed
32. Kulkarni, P. Current topics in research ethics in vaccine studies. Perspect. Clin. Res. 2013 4, 80–83 (2013). - PubMed
33. Hodgson, S. H. et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect. Dis. 21, e26-e352020 (2021). - PubMed
34. Boyle, P. We can’t defeat COVID-19 without vaccinating children. There aren’t even any kids’ clinical trials yet. AAMC (2020); https://www.aamc.org/news-insights/we-can-t-defeat-covid-19-without-vaccinating-children-there-arent-even-any-kids-clinical-trials-yet . - PubMed
35. Geoghegan, S. O’Callaghan, K. P. & Offit, P. A. Vaccine safety: myths and misinformation. Front. Microbiol. 11, 372 (2020). - PubMed
36. Davidson, M. Vaccination as a cause of autism-myths and controversies. Dialogues Clin. Neurosci. 19, 403–407 (2017). - PubMed
37. Doherty, M. et al. Vaccination of special populations: protecting the vulnerable. Vaccine. 34, 6681–6690 (2016). - PubMed
38. Goyal, M. K. et al. Racial and ethnic differences in emergency department pain management of children with fractures. Pediatrics 145, 1–11 (2020). - PubMed
39. Moore, J. T. et al. Disparities in incidence of COVID-19 among underrepresented racial/ethnic groups in counties identified as hotspots during June 5–18, 2020—22 States, February–June 2020. MMWR Morb. Mortal Wkly Rep. 69, 1122–1126 (2020). - PubMed
40. Kim, L. et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, March 1–July 25, 2020. MMWR Morb. Mortal Wkly Rep. 69, 1081–1088 (2020). - PubMed
41. Anandappa, M. et al. Racial disparities in vaccination for seasonal influenza in early childhood. Public Health 158, 1–8 (2018). - PubMed
42. Webb, N. S., Dowd-Arrow, B., Taylor, M. G. & Burdette, A. M. Racial/ethnic disparities in influenza vaccination coverage among US adolescents, 2010-2016. Public Health Rep. 133, 667–676 (2018). - PubMed
43. Woinarowicz, M. & Howell, M. Comparing vaccination coverage of American Indian children with White children in North Dakota. Public Health 186, 78–82 (2020). - PubMed
44. Santibanez, T. A. et al. Parental vaccine hesitancy and childhood influenza vaccination. Pediatrics 146, e2020007609 (2020). - PubMed
45. Aristizabal, P. et al. Participation in pediatric oncology research protocols: racial/ethnic, language and age-based disparities. Pediatr. Blood Cancer 62, 1337–1344 (2015). - PubMed
46. Missing from state plans to distribute the coronavirus vaccine: money to do it. The New York Times (2020); https://www.nytimes.com/2020/11/14/health/covid-vaccine-distribution-plans.html - PubMed
47. Edwards, K. M., et al. Countering vaccine hesitancy. Pediatrics 138, e20162146 (2016). - PubMed
48. Karafillakis, E. et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum. Vaccines Immunother. 15, 1615–1627 (2019). - PubMed
49. Simon, G. R. et al. Medical versus nonmedical immunization exemptions for child care and school attendance. Pediatrics 138, e20162145 (2016). - PubMed
50. Friedman, C. et al. Toward a science of learning systems: a research agenda for the high-functioning learning health system. J. Am. Med. Informatics Assoc. 22, 43–50 (2014). - PubMed
51. Cooper, D. M. et al. Reopening schools safely: the case for collaboration, constructive disruption of pre-coronavirus 2019 expectations, and creative solutions. J. Pediatr. 223, 183–185 (2020). - PubMed

Publication Types

• Journal Article
• Research Support, N.I.H., Extramural
• Research Support, Non-U.S. Gov't

Grant support

• UL1 TR001414/TR/NCATS NIH HHS/United States